| abstract |
The present invention relates to Form I of 3- (6- (1- (2,2-difluorobenzo [d] [1,3] dioxol-5-yl) cyclopropanecarboxamido) -3-methylpyridin-2-yl) The present invention relates to a benzoic acid formulation, a pharmaceutical pack or kit thereof, and a treatment method using them. The compound can exist as a pharmaceutically acceptable salt, and can also exist in the free form, referred to as Form I, described and characterized herein. Dosage units may further include bulking agents, disintegrants, surfactants, glidants, or viscosity agents, and / or lubricants. |